cover image - Edmunds' Pharmacology for the Primary Care Provider - Elsevier eBook on VitalSource, 5th Edition
ISBN: 9780323661690
Copyright: 2023
Publication Date: 07-07-2022
Page Count: 880
Imprint: Elsevier
List Price: $113.99

Edmunds' Pharmacology for the Primary Care Provider - Elsevier eBook on VitalSource, 5th Edition

by Constance G. Visovsky, PhD, RN, ACNP-BC, FAAN, Cheryl H. Zambroski, PhD, RN and Rebecca M. Lutz

Elsevier eBook on VitalSource

cover image - Edmunds' Pharmacology for the Primary Care Provider - Elsevier eBook on VitalSource, 5th Edition
ISBN: 9780323661690
Copyright: 2023
Publication Date: 07-07-2022
Page Count: 880
Imprint: Elsevier
List Price: $113.99
Was $113.99

Now $100.31

Or $0.00 with a valid access code

Master the pharmacologic principles and drug information you need to safely and effectively prescribe drugs for primary care! Edmunds' Pharmacology for the Primary Care Provider, 5th Edition is written for Nurse Practitioners, other Advanced Practice Nursing prescribers, and Physician Assistants. Unlike other pharmacotherapeutics textbooks, it focuses on the drugs most commonly used in primary care settings. A new chapter format and body-system approach make learning easier, and standardized clinical guidelines ensure best practices in pharmacotherapeutics. Updated and impeccably accurate drug content includes the latest drug classes, specific drugs, and therapeutic uses in primary care. Continuing to emphasize health promotion strategies, this new edition includes new chapters on pharmacogenetics, drugs for ADHD, nutritional supplements, and more.

Newer Edition Available

6th Edition

Pharmacology for the Primary Care Provider - Elsevier eBook on VitalSource

Elsevier eBook on VitalSource
ISBN: 9780443261619
    • Comprehensive pharmacotherapeutics content is written specifically for Nurse Practitioners, other Advanced Practice Nurses, and Physician Assistants
    • Focus on key drugs highlights the most commonly prescribed and most representative drugs of each major drug class — with particular emphasis on the top 100 prescribed drugs
    • Emphasis on patient teaching helps you communicate with patients and family caregivers to promote adherence to the drug regimen
    • Emphasis on health promotion describes how to help patients stay well and improve their health, including coverage of vitamins, weight management, immunizations and biologicals, and smoking cessation
    • Complementary and Alternative Therapies tables highlight significant dietary and herbal interactions with FDA-approved drugs
    • NEW! Thoroughly updated content reflects the latest drug information and current thinking on pharmacologic management
    • NEW macro- and chapter-level organization is based on body systems rather than drug classes, for better coverage of the medications prescribed for the health problems affecting specific body systems
    • NEW and UNIQUE! Chapter format begins with an overview of anatomy, physiology, and disease processes — as opposed to drug classes or drug types — and then follows the World Health Organization’s Process for Rational Prescribing, using a six-step approach to drug selection and discussing first-, second-, and third-line treatments for each specific problem
    • NEW! Practical learning aids include:
    • Black Box Warning boxes that draw attention to critical drug safety precautions.
    • Clinical Guidelines: Bookmark This features that identify websites where updated clinical guidelines can be found
    • Medication Dosages tables that include dose ranges, maintenance doses, and, where appropriate, plans for dose escalation and de-escalation (e.g., corticosteroids)
    • Practice Pearls boxes that highlight good prescribing practices, safety measures, follow-up recommendations, serum blood level monitoring, referrals to specialty providers, and other key prescriber tips
    • NEW! Prescribing Considerations unit addresses issues of medication adherence, prescription writing, cost, and quality assurance
    • NEW! Updated coverage of pain management reflects the current realities of substance use and the opioid crisis
  • Unit 1: Principles of Pharmacology for Advanced Practice
    1. Pharmacokinetics and Pharmacodynamics
    2. Pharmacogenomics

    Unit 2: Topical Medications
    3. Integumentary System Medications
    4. Eye and Ear Medications

    Unit 3: Pulmonary System Medications
    5. Allergy and Respiratory Medications
    6. Asthma Medications
    7. Chronic Obstructive Pulmonary Disease Medications

    Unit 4: Cardiovascular System Medications
    8. Antihyperlipidemic Medications
    9. Antihypertensive Medications
    10. Coronary Artery Disease Medications
    11. Heart Failure Medications
    12. Antiarrhythmic Medications

    Unit 5: Hematologic System Medications
    13. Anemia Medications
    14. Anticlotting Medications

    Unit 6: Gastrointestinal System Medications
    15. Gastroesophageal Reflux Disease, Gastritis, and Peptic Ulcer Disease Medications
    16. Constipation and Diarrhea Medications
    17. Antiemetic Medications

    Unit 7: Genitourinary System Medications
    18. Male Genitourinary Medications
    19. Urinary Incontinence Medications and Urinary Analgesics

    Unit 8: Reproductive System Medications
    20. Contraceptive Medications
    21. Medications for the Menopausal Transition

    Unit 9: Musculoskeletal System Medications
    22. Antiinflammatory Medications
    23. Disease-Modifying and Immune Therapy Medications
    24. Antigout Medications
    25. Osteoporosis Medications
    26. Muscle Relaxant Medications

    Unit 10: Central Nervous System Medications
    27. Migraine Headache Medications
    28. Attention-Deficit/Hyperactivity Disorder Medications
    29. Antiepileptic Medications
    30. Parkinson’s Disease Medications
    31. Dementia and Alzheimer’s Disease Medications
    32. Pain Management Medications and Substance Abuse

    Unit 11: Mental Health and Behavior-Modifying Medications
    33. Antianxiety and Insomnia Medications
    34. Mood Disorder Medications
    35. Antipsychotic Medications

    Unit 12: Endocrine System Medications
    36. Thyroid Medications
    37. Adrenal Gland Medications
    38. Diabetes Mellitus Medications

    Unit 13: Antiinfective Medications
    39. Principles for Prescribing Antiinfective Medications in Primary Care
    40. Penicillins
    41. Cephalosporins
    42. Tetracyclines
    43. Macrolides
    44. Fluoroquinolones
    45. Sulfonamides
    46. Antitubercular Medications
    47. Antifungal Medications
    48. Antiviral and Antiretroviral Medications
    49. Antiprotozoal Medications

    Unit 14: Health Promotion
    50. Immunizations and Immunomodulation Medications and Schedules
    51. Weight Management Medications
    52. Smoking Cessation Medications

    Unit 15: Prescribing Considerations
    53. Medication Adherence
    54. Cost, Quality Assurance, and Prescription Writing in Prescribing Medications
  • Constance G. Visovsky, PhD, RN, ACNP-BC, FAAN, Professor and Lewis and Leona Hughes Endowed Chair in Nursing Science, College of Nursing, University of South Florida, Tampa, Florida, USA, Cheryl H. Zambroski, PhD, RN, Associate Professor, College of Nursing, University of South Florida, Tampa, Florida, USA and Rebecca M. Lutz
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • All content can be read as read aloud speech or dynamic braille
      • Has alternative text descriptions for images
    • Conformance
    • Navigation
      • Table of contents to all chapters of the text via links
      • Index with links to referenced entries
      • Elements such as headings, tables, etc. for structured navigation
      • Page list to go to pages from the print source version
    • Rich Content
      • Math formulas in accessible format (MathML)
      • Information-rich images are described by extended descriptions
    • Hazards
      • The publication contains no hazards
    • Product Content
      • Content includes any type of illustrations.
      • The primary content is text.
      • Content includes maps and/or other cartographic content.
      • Content includes a significant number of actionable (clickable) web links to external content, downloadable resources, supplementary material, etc.
      • Content includes a significant number of actionable (clickable) cross-references, hyperlinked notes and annotations, or with other actionable links between largely textual elements (e.g., quiz/test questions, 'choose your own ending', etc.).
      • Content includes photographs, whether in a plate section / insert or not.
      • Content includes figures, diagrams, charts and/or graphs, including other 'mechanical' (i.e. non-photographic) illustrations.
      • Content includes images displayed in a specific order for the purpose of graphic storytelling or giving information (e.g. graphic novels, comics and manga). May include text integrated into the image (as speech and thought bubbles, textual 'sound' effects, captions etc.).
      • Content includes text within images, including text-as-text embedded in diagrams, charts, or within images containing speech balloons, thought bubbles, captions, etc.
      • Content includes visual content that is purely decorative and is not necessary to understanding of the content.
      • Content includes chemical notations, formulae.
      • Content includes mathematical notations, formulae.
      • At least some text - including text within other images - is 'text as an image' (i.e., a picture of text).
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • Content is enhanced with ARIA roles to optimize organization and facilitate navigation
      • Page breaks included from the original print source
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • The body text is presented with a contrast ratio of at least 4.5:1 (or 3:1 for large/heading text)
      • Ultra-high contrast between text and background
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • Content provides explanations for unusual words, abbreviations, acronyms, idioms, jargon in an accessible form, such as glossaries, scripted pop-ups.
      • Where interactive content is included in the product, controls are provided (e.g., for speed, pause and resume, reset) and labelled to make their use clear.
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
Was $113.99

Now $100.31

Or $0.00 with a valid access code